teaser
↓Article continues below this sponsored advert↓
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE
↑Advertisement↑
It comes as no surprise but Sanofi-Aventis has withdrawn its marketing application to gain approval in the USA for its obesity drug Acomplia